Three of the breast cancer cell lines sensitive to a reduction in RNMT have oncogenic hotspot activating PIK3CA mutations; MCF7 expresses PIK3CA E545 K, T47D expresses PIK3CA H1047R, and JIMT-1 expresses PIK3CA C420R (table 1; electronic supplementary material, figure S1). This evidence concerns the gene PIK3CA and breast carcinoma.